A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

Alzheimer’s, dementia webinar More than 6 million individuals are living with Alzheimer’s disease in the U.S., and there are ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

Residents from Erie and surrounding counties participated in this year’s Erie Shores Walk to End Alzheimer’s, raising a record-breaking $103,000 to support the care, support and research programs ...

Age-adjusted dementia deaths rates were stable between 2018 and 2019, then increased in 2020 and decreased slightly in 2022, ...

The novel SLC9A7 locus is believed to have downstream effects on amyloid β accumulation. The SLC9A7 is a novel locus associated with the risk for Alzheimer disease (AD), according to study results ...

Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of ...

A new interdisciplinary study at the University of Delaware seeks to study AD by examining changes in the arteries and brain ...